Condition
Painful Peripheral Neuropathy
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
P 2 (1)
Trial Status
Unknown2
Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT06614322Phase 2RecruitingPrimary
SPENDD: Quantitative Sensory Testing and Analgesic Response for Painful Peripheral Neuropathy.
NCT03275233UnknownPrimary
Psychiatric Comorbidities in Patients With Painful Peripheral Neuropathy
NCT02243475UnknownPrimary
Probing the Role of Sodium Channels in Painful Neuropathies
Showing all 3 trials